Acquisition Opportunity Worldwide Clinical Trials has announced the acquisition of Catalyst Clinical Research, signaling a strategic consolidation in the CRO space. This presents an immediate cross-sell and integration opportunity to align Catalyst’s capabilities with Worldwide’s broader global platform and client base.

Expanded Global Footprint Catalyst’s integration into Worldwide expands the global reach to over 70 countries. This creates sales potential to onboard sponsors seeking a seamless, multinational development partner with diversified therapeutic expertise and centralized program management.

Awarded Expertise Recent recognitions in clinical trial management and workplaces accolades position the entity as a reputable partner. Leverage these achievements in proposals to win new studies and retain existing clients seeking proven performance and strong operational execution.

Therapeutic Focus Worldwide emphasizes neuroscience, oncology, rare disease, and internal medicine. Align sales conversations to highlight Catalyst’s capabilities within these therapeutic areas, targeting sponsors with late-stage or pivotal trials that require robust data transparency and flexible service models.

Technology Stack Utilize the modern tech stack including AWS, Kafka, continuous delivery, and Salesforce to offer scalable, transparent, and secure study operations. Position as a tech-enabled partner capable of handling complex data flows, real-time insights, and efficient sponsor collaboration.